Nasdaq Welcomes Nightstar Therapeutics Nightstar plc (Nasdaq: NITE) to The Nasdaq Stock Market
29 September 2017 - 8:03AM
Nightstar Therapeutics plc (Nasdaq:NITE), a leading clinical-stage
gene therapy company, rang the closing bell at the Nasdaq
MarketSite in Times Square today in celebration of its initial
public offering (IPO) on The Nasdaq Stock Market.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/f735cbc8-df61-417e-9a3a-3dee84c8a5ed
http://www.globenewswire.com/NewsRoom/AttachmentNg/ea0abfbd-e1c2-43e7-9091-8d8c86fb60ce
Nightstar Therapeutics focuses on developing and commercializing
novel one-time treatments for patients suffering from rare
inherited retinal diseases that would otherwise progress to
blindness. Through their expertise in ophthalmology, gene therapy
and drug development, they are developing a pipeline of proprietary
product candidates that are designed to substantially modify or
halt the progression of inherited retinal diseases for which there
are no currently approved treatments.
“Nightstar Therapeutics continues to innovate in life changing
treatments,” said Nelson Griggs, President of the Nasdaq Stock
Exchange, “We are extremely proud to partner with them as they
continue to break barriers in the health care sector as a public
company.”
The information contained above is provided for informational
and educational purposes only, and nothing contained herein should
be construed as investment advice, either on behalf of a particular
security or an overall investment strategy. Information about the
company is provided by the company or comes from the company’s
public filings and is not independently verified by Nasdaq.
Neither Nasdaq nor any of its affiliates makes any recommendation
to buy or sell any security or any representation about the
financial condition of any company. Statements regarding
Nasdaq-listed companies are not guarantees of future performance.
Actual results may differ materially from those expressed or
implied. Past performance is not indicative of future results.
Investors should undertake their own due diligence and carefully
evaluate companies before investing. ADVICE FROM A SECURITIES
PROFESSIONAL IS STRONGLY ADVISED.
About NasdaqNasdaq (Nasdaq:NDAQ) is a
leading global provider of trading, clearing, exchange technology,
listing, information and public company services. Through its
diverse portfolio of solutions, Nasdaq enables customers to plan,
optimize and execute their business vision with confidence, using
proven technologies that provide transparency and insight for
navigating today's global capital markets. As the creator of the
world's first electronic stock market, its technology powers more
than 90 marketplaces in 50 countries, and 1 in 10 of the world's
securities transactions. Nasdaq is home to approximately
3,900 total listings with a market value of approximately $12
trillion. To learn more,
visit: http://business.nasdaq.com.
Media Relations Contacts:Stephanie
Lowenthal(646) 441-5073Stephanie.Lowenthal@nasdaq.com
Emily Pan(646) 441-5120emily.pan@nasdaq.com
- NDAQG -
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jul 2023 to Jul 2024